Jasper Therapeutics is trading at $0.60 (+5.24%) after announcing two senior appointments covering regulatory affairs and clinical development, though their connection to the after-hours move is unconfirmed.
- The appointments were announced on September 15, 2026.
- The company disclosed inducement options for 243,000 shares at a $0.6328 exercise price.
- The release announced no clinical results, regulatory decision, earnings update, or explicit explanation for the move; broader markets declined.